Edit search
Dendritic cell vaccination in combination with anti-CD25 mon…
Dendritic cell vaccination in combination with anti-CD25 monoclonal antibody treatment%3A a phase I%2FII study in metastatic melanoma patients.
Dendritic cell vaccination in combination with anti-CD25 monoclonal antibody treatment%3A a phase I%2FII study in metastatic melanoma patients.
Article, Chapter
Authors: J.F.M. Jacobs
Publication: Volume:16, Issue:20, Page(s):5067-5078
Published: 2010
Browse related articles
  Request a copy of this item
Cite this item